Haemonetics Corporation (FRA:HAZ)

Haemonetics Revenue

Haemonetics had revenue of $327.32M USD in the quarter ending September 27, 2025, a decrease of -5.27%. This brings the company's revenue in the last twelve months to $1.33B, down -2.45% year-over-year. In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth.

• Revenue (ttm): $1.33B
• Revenue Growth: -2.45%
• P/S Ratio: 2.89
• Revenue / Employee: $439.25K
• Employees: 3,023
• Market Cap: 3.28B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 29, 2025	1.36B	51.77M	3.95%
Mar 30, 2024	1.31B	140.40M	12.01%
Apr 1, 2023	1.17B	175.46M	17.67%
Apr 2, 2022	993.20M	122.73M	14.10%
Apr 3, 2021	870.46M	-118.02M	-11.94%
Mar 28, 2020	988.48M	20.90M	2.16%
Mar 30, 2019	967.58M	63.66M	7.04%
Mar 31, 2018	903.92M	17.81M	2.01%
Apr 1, 2017	886.12M	-22.72M	-2.50%
Apr 2, 2016	908.83M	-1.54M	-0.17%
Mar 28, 2015	910.37M	-28.14M	-3.00%
Mar 29, 2014	938.51M	46.52M	5.22%
Mar 30, 2013	891.99M	164.15M	22.55%
Mar 31, 2012	727.84M	51.15M	7.56%
Apr 2, 2011	676.69M	31.26M	4.84%
Apr 3, 2010	645.43M	47.55M	7.95%
Mar 28, 2009	597.88M	81.44M	15.77%
Mar 29, 2008	516.44M	66.83M	14.86%
Mar 31, 2007	449.61M	29.87M	7.12%
Apr 1, 2006	419.73M	-	-